Pulse Biosciences (PLSE) had the highest return between January 1, 2017 and March 31, 2017 by a small-cap US stock, returning 214%.
| ASSET | DATE | % RETURN |
|---|---|---|
Pulse Biosciences (PLSE) | 1/1/2017 - 3/31/2017 | 214% |
Talos Energy (TALO) | 1/1/2017 - 3/31/2017 | 186.78% |
Esperion Therapeutics (ESPR) | 1/1/2017 - 3/31/2017 | 175.86% |
Assembly Biosciences (ASMB) | 1/1/2017 - 3/31/2017 | 112.33% |
United States Antimony (UAMY) | 1/1/2017 - 3/31/2017 | 105.64% |
Aehr Test Systems (AEHR) | 1/1/2017 - 3/31/2017 | 105.56% |
Gravity (GRVY) | 1/1/2017 - 3/31/2017 | 98.85% |
Benitec Biopharma Ltd ADR (BNTC) | 1/1/2017 - 3/31/2017 | 95.74% |
Syndax Pharmaceuticals (SNDX) | 1/1/2017 - 3/31/2017 | 90.56% |
Palvella Therapeutics (PVLA) | 1/1/2017 - 3/31/2017 | 88.41% |
Nektar Therapeutics (NKTR) | 1/1/2017 - 3/31/2017 | 88.06% |
Cronos (CRON) | 1/1/2017 - 3/31/2017 | 87.39% |
Safe Bulkers (SB) | 1/1/2017 - 3/31/2017 | 83.33% |
Hello (MOMO) | 1/1/2017 - 3/31/2017 | 82.19% |
Verastem (VSTM) | 1/1/2017 - 3/31/2017 | 81.58% |
Ichor (ICHR) | 1/1/2017 - 3/31/2017 | 79.95% |
Chemours (CC) | 1/1/2017 - 3/31/2017 | 78.48% |
LightPath Technologies (LPTH) | 1/1/2017 - 3/31/2017 | 77.92% |
Tronox (TROX) | 1/1/2017 - 3/31/2017 | 76.15% |
Ultra Clean (UCTT) | 1/1/2017 - 3/31/2017 | 73.92% |
AnaptysBio (ANAB) | 1/1/2017 - 3/31/2017 | 73.44% |
XOMA (XOMA) | 1/1/2017 - 3/31/2017 | 69.29% |
Mesoblast (MESO) | 1/1/2017 - 3/31/2017 | 67.85% |
Harrow Health (HROW) | 1/1/2017 - 3/31/2017 | 66.8% |
Genco Shipping & Trading (GNK) | 1/1/2017 - 3/31/2017 | 66.67% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
